228
Views
7
CrossRef citations to date
0
Altmetric
Meta-analysis

Risk of selected gastrointestinal toxicities in metastatic renal cell carcinoma patients treated with immuno-TKI combinations: a meta-analysis

, , &
Pages 1225-1232 | Received 21 Mar 2021, Accepted 23 Jun 2021, Published online: 01 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Zhimin Su, Linbin Lu, Fuyu Chen, Jianhui Chen & Xiong Chen. (2021) Gut Microbiota and Sunitinib-Induced Diarrhea in Metastatic Renal Cell Carcinoma: A Pilot Study. Cancer Management and Research 13, pages 8663-8672.
Read now
Gang Wang, Fangfang Qu, Shouyong Liu, Jincai Zhou & Yi Wang. (2021) Nucleolar protein NOP2 could serve as a potential prognostic predictor for clear cell renal cell carcinoma. Bioengineered 12:1, pages 4841-4855.
Read now

Articles from other publishers (5)

Cynthia Liu, Rajan Amin, Malek Shatila, Nicholas Short, Mehmet Altan, Amishi Shah, Omar Alhalabi, Pablo Okhuysen, Anusha S. Thomas & Yinghong Wang. (2022) Clinical characteristics and outcomes of tyrosine kinase inhibitor-related lower GI adverse effects. Journal of Cancer Research and Clinical Oncology 149:7, pages 3965-3976.
Crossref
Robert Motzer, Saby George, Jaime R Merchan, Thomas E Hutson, Xun Song, Rodolfo F Perini, Ran Xie, Urmi Bapat & Javier Puente. (2023) Characterization and Management of Adverse Reactions From the CLEAR Study in Advanced Renal Cell Carcinoma Treated With Lenvatinib Plus Pembrolizumab. The Oncologist 28:6, pages 501-509.
Crossref
Rosa Maria Paragliola, Francesco Torino, Agnese Barnabei, Giovanni Maria Iannantuono, Andrea Corsello, Pietro Locantore & Salvatore Maria Corsello. (2023) Bone Metabolism Effects of Medical Therapy in Advanced Renal Cell Carcinoma. Cancers 15:2, pages 529.
Crossref
Haoran Li, Kamal K. Sahu & Benjamin L. Maughan. (2022) Mechanism and Management of Checkpoint Inhibitor-Related Toxicities in Genitourinary Cancers. Cancers 14:10, pages 2460.
Crossref
Mário Fontes-Sousa, Helena Magalhães, Alicia Oliveira, Filipa Carneiro, Filipa Palma dos Reis, Pedro Silvestre Madeira & Sara Meireles. (2022) Reviewing Treatment Options for Advanced Renal Cell Carcinoma: Is There Still a Place for Tyrosine Kinase Inhibitor (TKI) Monotherapy?. Advances in Therapy 39:3, pages 1107-1125.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.